Delivery Order SPE2DB22D1106-SPE2DB25FEEW2
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $35,250.60, is a Firm Fixed Price Delivery Order with an ultimate completion date of October 18, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
The federal contract award is to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of RINVOQ ER 15 MG TABLET UU 30S. The contract, valued at $11,149.90, was awarded by the Defense Logistics Agency (DLA) on January 8, 2025, with a completion date of January 9, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The $45,404.89 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 10, 2024 with a completion date of June 11, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a vehicle for providing a...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $6,223.32, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 15, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,020.55 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 3, 2024 with a completion date of June 4, 2024. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 30 MG TABLET UU 30S. The contract has a ceiling value of $38,667.19 and a period of performance ending on July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $6,555.96. The contract has an ultimate completion date of November 1, 2024 and is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite...
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,764.91 firm-fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 12, 2024 and was awarded on March 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S pharmaceutical product to the Defense Logistics Agency (DLA). The $15,655.73 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2024 with a completion date of July 18, 2024. The contract is a delivery order under the agency's existing $999,999,999 Indefinite Delivery Contract (IDC) with Amerisourcebergen, which provides a broad range of...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The contract, valued at $10,836.57, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...